ES522678A0 - Un procedimiento para la preparacion de nuevos derivados de 2-oxo-imidazolina. - Google Patents

Un procedimiento para la preparacion de nuevos derivados de 2-oxo-imidazolina.

Info

Publication number
ES522678A0
ES522678A0 ES522678A ES522678A ES522678A0 ES 522678 A0 ES522678 A0 ES 522678A0 ES 522678 A ES522678 A ES 522678A ES 522678 A ES522678 A ES 522678A ES 522678 A0 ES522678 A0 ES 522678A0
Authority
ES
Spain
Prior art keywords
oxo
procedure
preparation
new
imidazoline derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES522678A
Other languages
English (en)
Other versions
ES8503667A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Pharma Corp
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Publication of ES522678A0 publication Critical patent/ES522678A0/es
Publication of ES8503667A1 publication Critical patent/ES8503667A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES522678A 1982-05-24 1983-05-24 Un procedimiento para la preparacion de nuevos derivados de 2-oxo-imidazolina. Expired ES8503667A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57088637A JPS6058233B2 (ja) 1982-05-24 1982-05-24 ２−オキソイミダゾリジン誘導体及びその製法

Publications (2)

Publication Number Publication Date
ES522678A0 true ES522678A0 (es) 1985-03-16
ES8503667A1 ES8503667A1 (es) 1985-03-16

Family

ID=13948325

Family Applications (2)

Application Number Title Priority Date Filing Date
ES522678A Expired ES8503667A1 (es) 1982-05-24 1983-05-24 Un procedimiento para la preparacion de nuevos derivados de 2-oxo-imidazolina.
ES535980A Granted ES535980A0 (es) 1982-05-24 1984-09-17 Un procedimiento para la preparacion de nuevos derivados de 2-oxo-imidazolina

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES535980A Granted ES535980A0 (es) 1982-05-24 1984-09-17 Un procedimiento para la preparacion de nuevos derivados de 2-oxo-imidazolina

Country Status (8)

Country Link
US (1) US4508727A (es)
EP (1) EP0095163B1 (es)
JP (1) JPS6058233B2 (es)
DE (2) DE19975013I1 (es)
ES (2) ES8503667A1 (es)
HK (1) HK32689A (es)
MY (1) MY100095A (es)
SG (1) SG5989G (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61293538A (ja) * 1985-06-24 1986-12-24 Shinto Paint Co Ltd 固体または半固体溶質の溶媒による溶解方法
KR930004646B1 (ko) * 1986-12-09 1993-06-02 다나베 세이야꾸 가부시끼가이샤 심기능 부전의 예방 및 치료제
DE3782229T2 (de) * 1986-12-12 1993-03-04 Tanabe Seiyaku Co Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
FR2620700B1 (fr) * 1987-09-17 1990-06-01 Adir Procede de synthese d'alpha amino acides n alkyles et leurs esters. application a la synthese de carboxyalkyl dipeptides
JPH0645603B2 (ja) * 1988-12-16 1994-06-15 田辺製薬株式会社 光学活性２‐オキソイミダゾリジン誘導体の製法
JPH07121916B2 (ja) * 1993-12-10 1995-12-25 田辺製薬株式会社 光学活性３−アシル−２−オキソイミダゾリジン−４−カルボン酸誘導体及びその製法
CN1681495B (zh) 2002-08-19 2010-05-12 辉瑞产品公司 用于治疗过度增生性疾病的组合物
CL2004000366A1 (es) * 2003-02-26 2005-01-07 Pharmacia Corp Sa Organizada B USO DE UNA COMBINACION DE UN COMPUESTO DERIVADO DE PIRAZOL INHIBIDOR DE QUINASA p38, Y UN INHIBIDOR DE ACE PARA TRATAR DISFUNCION RENAL, ENFERMEDAD CARDIOVASCULAR Y VASCULAR, RETINOPATIA, NEUROPATIA, EDEMA, DISFUNCION ENDOTELIAL O INSULINOPATIA.
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
JP4780437B2 (ja) * 2004-12-08 2011-09-28 大原薬品工業株式会社 ２−オキソイミダゾリジン誘導体の製造方法
JP4799085B2 (ja) * 2005-09-02 2011-10-19 株式会社カネカ 光学活性ｎ置換アミノアシル環状尿素誘導体の製造法
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US8404896B2 (en) 2006-12-01 2013-03-26 Bristol-Myers Squibb Company N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
JP5206926B2 (ja) * 2007-07-30 2013-06-12 株式会社Ｄｎｐファインケミカル宇都宮 塩酸イミダプリルの製造方法
MX2014002163A (es) 2011-08-26 2014-09-25 Wockhardt Ltd Métodos para el tratamiento de desórdenes cardiovasculares.
BR112015026513A2 (pt) 2013-04-17 2017-07-25 Pfizer derivados de n-piperidin-3-ilbenzamida para tratar as doenças cardiovasculares
CN104119424B (zh) * 2014-07-01 2018-12-18 上海天慈生物谷生物工程有限公司 (4s)-3-[(2s)-2[(1s)-1-乙氧羰基-3-苯丙基]氨基丙酰基]-1-甲基-2-氧代咪唑啉-4-羧酸的制备方法
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CN105713068B (zh) * 2014-12-04 2021-04-20 湖南九典制药股份有限公司 一种制备咪达普利关键中间体及其衍生物的方法
RS66416B1 (sr) 2019-01-18 2025-02-28 Astrazeneca Ab 6'-[[(1s,3s)-3-[[5-(difluorometoksi)-2-pirimidinil]amino]ciklopentil]amino][1(2h),3'-bipiridin]-2-on kao inhibitor pcsk9 i metode njegove primene

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL58849A (en) * 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
GR75019B (es) * 1980-09-17 1984-07-12 Univ Miami
US4296110A (en) * 1980-10-28 1981-10-20 E. I. Du Pont De Nemours And Company Antihypertensive I-substituted cyclic lactam-2-carboxylic acids
JPS5788165A (en) * 1980-11-21 1982-06-01 Tanabe Seiyaku Co Ltd 2-oxoimidazolidine-4-carboxylic acid derivative and its preparation
JPS5835114A (ja) * 1981-08-21 1983-03-01 ザ・ユニバ−シイテイ・オブ・マイアミ 抗高血圧剤

Also Published As

Publication number Publication date
DE19975013I1 (de) 2003-09-04
JPS6058233B2 (ja) 1985-12-19
US4508727A (en) 1985-04-02
ES8603427A1 (es) 1985-12-16
MY100095A (en) 1989-10-10
EP0095163B1 (en) 1987-08-19
EP0095163A2 (en) 1983-11-30
JPS58203971A (ja) 1983-11-28
HK32689A (en) 1989-04-28
EP0095163A3 (en) 1984-09-12
DE3373100D1 (en) 1987-09-24
ES8503667A1 (es) 1985-03-16
SG5989G (en) 1989-06-09
ES535980A0 (es) 1985-12-16

Similar Documents

Publication Publication Date Title
ES521121A0 (es) Un procedimiento para la preparacion de derivados de benzotia-zolsulfonamida.
ES528630A0 (es) Un procedimiento para la obtencion de derivados de hexahidro-3-oxo-piridinas.
ES518225A0 (es) Un procedimiento para la preparacion de nuevos derivados de oxabicicloalcano.
ES521635A0 (es) Un procedimiento para la preparacion de nuevos derivados de fosfolipidos.
ES520132A0 (es) Un procedimiento para la preparacion de derivados de 1-normon-2-ilo.
ES524446A0 (es) Un procedimiento para la preparacion de nuevos derivados.
ES520730A0 (es) Un procedimiento para la prepracion de nuevas benzolactamas.
ES522678A0 (es) Un procedimiento para la preparacion de nuevos derivados de 2-oxo-imidazolina.
ES524447A0 (es) Un procedimiento para la preparacion de nuevos derivados arilfenolicos.
ES505922A0 (es) Un procedimiento para la preparacion de nuevos derivados de cefalospirina.
ES516825A0 (es) Un procedimiento para la preparacion de nuevos derivados de 3-amino-pregn-5-eno.
ES524610A0 (es) Un procedimiento para la preparacion de nuevos derivados de fosfolipidos.
ES522120A0 (es) Un procedimiento para la preparacion de 4-aril-4-piperidincarbinoles.
ES524317A0 (es) Un procedimiento para la preparacion de nuevos derivados de tienopirimidina.
ES510067A0 (es) Un procedimiento para la preparacion de nuevos derivados de benzoilurea.
ES511224A0 (es) Un procedimiento para la preparacion de nuevos derivados de 2-piperazino pirimioina.
ES521192A0 (es) Un procedimiento para la preparacion de derivados de b-lactama.
ES533389A0 (es) Un procedimiento para la preparacion de nuevos derivados de tiosulfonamida.
ES504793A0 (es) Un procedimiento para la preparacion de nuevos derivados de caprilolactama.
ES534642A0 (es) Un procedimiento para la preparacion de nuevos derivados de carbaciclina.
ES522389A0 (es) Un procedimiento para la preparacion de nuevos derivados de penem-2-tiosustituidos.
ES534269A0 (es) Un procedimiento para la preparacion de nuevos derivados de difeniletanona.
ES507482A0 (es) Un procedimiento para la preparacion de nuevos derivados de acilaminoquimazolina.
ES526528A0 (es) Un procedimiento para la preparacion de derivados de difenilalquilenicos.
ES527780A0 (es) Un procedimiento para la preparacion de nuevas espiro-3-azolindionas.